Probe Metals Inc. (CVE:PRB), a gold junior, moved up after announcing drill results from its Val-d’Or East project in Quebec
Sean Mason | December 6, 2016 | SmallCapPower
A gold junior glistered following drill results Tuesday. Here’s some small stocks making big moves on Tuesday, December 6, 2016 (as of 4 pm EST):
Probe Metals Inc. (CVE:PRB) shares shot up 23% to $1.44 on Tuesday after the gold junior announced results from the ongoing drilling program on its 100% owned Val-d’Or East project in Quebec, which included 12.6 g/t gold over 7.3 metres.
As well, shares of Neovasc Inc. (TSE:NVC) surged 69% to $3.21 as the specialty medical device company said it has experienced a technical success rate of 86% with its Tiara transcatheter mitral valve implantations.
Revive Therapeutics Ltd. (CVE:RVV), meanwhile, reported what it called “positive final study results” of REV-003 (Tianeptine) from its research collaboration with Rettsyndrome.org for the potential treatment of Rett syndrome. Revive Therapeutics stock popped 25% to $0.125 following the announcement.
Finally, DIAGNOS Inc. (CVE:ADK) shares gained 29% to $0.135 after the provider of Artificial Intelligence for healthcare technical services announced a pilot project contract for diabetic macular edema and diabetic retinopathy screening with BAYER Canada.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
